JAK2 and myelofibrosis: Additionally, we included all-cause death as part of our outcome of interest, and, therefore, the contribution of JAK2 mutation and WBC on CV-specific death is unclear, given that these variables are also risk factors for non-CV death, including transformation to acute leukemia or myelofibrosis.